Effect of thanatophoric dysplasia type i mutations on FGFR3 dimerization

Biophysical Journal

Volumn 108, Issue 2, 2015, Pages 272-278

  Del Piccolo, Nuala ^a   Placone, Jesse ^a   Hristova, Kalina ^a  

^a Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA;

FGFR3 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR RECEPTOR 3;

ANIMAL; CHEMISTRY; CHO CELL LINE; CRICETULUS; DEFICIENCY; GENETICS; HAMSTER; HUMAN; METABOLISM; MISSENSE MUTATION; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; THANATOPHORIC DWARFISM;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; HUMANS; MUTATION, MISSENSE; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; THANATOPHORIC DYSPLASIA;

EID: 84921463220     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2014.11.3460     Document Type: Article

References (39)

1. M.M. Cohen Jr. The new bone biology: pathologic, molecular, and clinical correlates Am. J. Med. Genet. A. 140 2006 2646 2706
2. M.M. Cohen Jr. Some chondrodysplasias with short limbs: molecular perspectives Am. J. Med. Genet. 112 2002 304 313
3. M.R. Passos-Bueno, and W.R. Wilcox H. Kitoh Clinical spectrum of fibroblast growth factor receptor mutations Hum. Mutat. 14 1999 115 125
4. F. Rousseau, and V. el Ghouzzi J. Bonaventure Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1) Hum. Mol. Genet. 5 1996 509 512
5. C.G.M. L'Horte, and M.A. Knowles Cell responses to FGFR3 signaling: growth, differentiation and apoptosis Experim. Cell Res. 304 2005 417 431
6. P.L. Tavormina, and R. Shiang J.J. Wasmuth Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3 Nat. Genet. 9 1995 321 328
7. R. Adar, and E. Monsonego-Ornan A. Yayon Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization J. Bone Miner. Res. 17 2002 860 868
8. P.Y. d'Avis, and S.C. Robertson D.J. Donoghue Constitutive activation of fibroblast growth factor receptor 3 by mutations responsible for the lethal skeletal dysplasia thanatophoric dysplasia type I Cell Growth Differ. 9 1998 71 78
9. P. Krejci, and L. Salazar W.R. Wilcox Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal dysplasia undermines dominant role of STAT1 in FGFR3 signaling in cartilage PLoS ONE 3 2008 e3961 10.1371/journal.pone.0003961
10. M.C. Naski, and Q. Wang D.M. Ornitz Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia Nat. Genet. 13 1996 233 237
11. J. Bonaventure, W.C. Horne, and R. Baron The localization of FGFR3 mutations causing thanatophoric dysplasia type I differentially affects phosphorylation, processing and ubiquitylation of the receptor FEBS J. 274 2007 3078 3093
12. D. Harada, and Y. Yamanaka Y. Seino FGFR3-related dwarfism and cell signaling J. Bone Miner. Metab. 27 2009 9 15
13. C. Deng, and A. Wynshaw-Boris P. Leder Fibroblast growth factor receptor 3 is a negative regulator of bone growth Cell 84 1996 911 921
14. S. Foldynova-Trantirkova, W.R. Wilcox, and P. Krejci Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias Hum. Mutat. 33 2012 29 41
15. R. Goetz, and M. Mohammadi Exploring mechanisms of FGF signalling through the lens of structural biology Nat. Rev. Mol. Cell Biol. 14 2013 166 180
16. D.M. Ornitz FGFs, heparan sulfate and FGFRs: complex interactions essential for development BioEssays 22 2000 108 112
17. D.M. Ornitz, and N. Itoh Fibroblast growth factors Genome Biol. 2 2001 3005
18. H. Greulich, and B. Kaplan M. Meyerson Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2 Proc. Natl. Acad. Sci. USA 109 2012 14476 14481
19. J.E. Phay, and M.H. Shah Targeting RET receptor tyrosine kinase activation in cancer Clin. Cancer Res. 16 2010 5936 5941
20. G. Iyer, and M.I. Milowsky Fibroblast growth factor receptor-3 in urothelial tumorigenesis Urol. Oncol. 31 2013 303 311
21. L. Chen, and L. Novicky K. Hristova Measuring the energetics of membrane protein dimerization in mammalian membranes J. Am. Chem. Soc. 132 2010 3628 3635
22. L. Chen, and J. Placone K. Hristova The extracellular domain of fibroblast growth factor receptor 3 inhibits ligand-independent dimerization Sci. Signal. 3 2010 ra86
23. N. Del Piccolo, and J. Placone K. Hristova Production of plasma membrane vesicles with chloride salts and their utility as a cell membrane mimetic for biophysical characterization of membrane protein interactions Anal. Chem. 84 2012 8650 8655
24. S. Sarabipour, C. King, and K. Hristova Uninduced high-yield bacterial expression of fluorescent proteins Anal. Biochem. 449 2014 155 157
25. E. Li, and J. Placone K. Hristova Quantitative measurements of protein interactions in a crowded cellular environment Anal. Chem. 80 2008 5976 5985
26. P.K. Wolber, and B.S. Hudson An analytic solution to the Förster energy transfer problem in two dimensions Biophys. J. 28 1979 197 210
27. C. King, and S. Sarabipour K. Hristova The FRET signatures of noninteracting proteins in membranes: simulations and experiments Biophys. J. 106 2014 1309 1317
28. T.H. Evers, and E.M.W.M. van Dongen M. Merkx Quantitative understanding of the energy transfer between fluorescent proteins connected via flexible peptide linkers Biochemistry 45 2006 13183 13192
29. P.R. Bevington Data reduction and error analysis for the physical sciences 1969 McGraw-Hill Book Company New York
30. R.E. Scott Plasma membrane vesiculation: a new technique for isolation of plasma membranes Science 194 1976 743 745
31. R.E. Scott, and P.B. Maercklein Plasma membrane vesiculation in 3T3 and SV3T3 cells. II. Factors affecting the process of vesiculation J. Cell Sci. 35 1979 245 252
32. R.E. Scott, and R.G. Perkins P.B. Maercklein Plasma membrane vesiculation in 3T3 and SV3T3 cells. I. Morphological and biochemical characterization J. Cell Sci. 35 1979 229 243
33. J. Placone, and K. Hristova Direct assessment of the effect of the Gly380Arg achondroplasia mutation on FGFR3 dimerization using quantitative imaging FRET PLoS ONE 7 2012 e46678
34. J. Placone, and L. He K. Hristova Strong dimerization of wild-type ErbB2/Neu transmembrane domain and the oncogenic Val664Glu mutant in mammalian plasma membranes Biochim. Biophys. Acta 1838 2014 2326 2330
35. S. Sarabipour, and K. Hristova Glycophorin A transmembrane domain dimerization in plasma membrane vesicles derived from CHO, HEK 293T, and A431 cells Biochim. Biophys. Acta 1828 2013 1829 1833
36. S. Sarabipour, and K. Hristova FGFR3 transmembrane domain interactions persist in the presence of its extracellular domain Biophys. J. 105 2013 165 171
37. E. Freire, and B. Snyder Quantitative characterization of the lateral distribution of membrane proteins within the lipid bilayer Biophys. J. 37 1982 617 624
38. S.F. Betz Disulfide bonds and the stability of globular proteins Protein Sci. 2 1993 1551 1558
39. A. McAuley, and J. Jacob M. Matsumura Contributions of a disulfide bond to the structure, stability, and dimerization of human IgG1 antibody CH3 domain Protein Sci. 17 2008 95 106